1. Sugimachi K, Tanaka S, Taguchi K, et al. Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma. J Clin Pathol, 2003, 56: 854–860.
2. Chen XM, Luo PF, Lin HH et al. Protocol of Interventional Treatment for Hepatocellular Carcinoma. Chinese-German J Clin Oncol, 2005, 4: 112–115.
3. Wang ZM, Wu ZQ. The staging of Appearances of DSA and Its clinical significance in patients with primary Hepatocellular carcinoma (HCC) and medical stage and late. J Pract Radiol (Chinese), 1998, 14, 268–269.
4. Shao GL. Angiogenasis and Interventional therapy for liver carcinoma. Clin Radiol (Foreign Medical Science) (Chinese), 2000, 23: 22–25.
5. Zhao JJ, Hu JQ, Cai JQ, et al. Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma. Chin J Oncol (Chinese), 2001, 23: 389–392.